CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 651 - 660 of 666
Study Number Lead Group Study Title CIRB Study Status
MAY2016-08-01 CLO-Mayo Clinic A Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer Cancer Prevention and Control CIRB Available to Open
NHLBI-MDS ECOG The National Myelodysplastic Syndromes (MDS) Study Cancer Prevention and Control CIRB Available to Open
EAQ162CD ECOG-ACRIN Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent Cancer Prevention and Control CIRB Available to Open
WF-97116 NCORP-Wake Forest University A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors with Cognitive Impairment Cancer Prevention and Control CIRB Available to Open
A211401 Alliance Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes Cancer Prevention and Control CIRB Available to Open
A221504 Alliance A Randomized; Double-Blind; Placebo-Controlled Pilot Study of an Oral; Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer (Adenocarcinoma) Cancer Prevention and Control CIRB Available to Open
NWU2015-06-04 CLO-Northwestern University Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with DCIS of the breast Cancer Prevention and Control CIRB Available to Open
NRG-CC004 NRG Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire In Women With Breast or Gynecologic Cancer Cancer Prevention and Control CIRB Available to Open
EA1151 ECOG-ACRIN Tomosynthesis Mammographic Imaging Screening Trial (TMIST) Cancer Prevention and Control CIRB Available to Open
UWI2016-07-01 CLO-University of Wisconsin Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment Cancer Prevention and Control CIRB Available to Open
Displaying 651 - 660 of 666